Post

Sharps Injury Prevention Features in Medical Devices: Testing and Documentation Requirements

This guidance document is focused on medical devices that contain a sharps injury prevention feature, which is designed with a component or attachment (either active or passive) that protects users from sharps injuries. The guidance specifically excludes sharps containers and needle recapping devices.

  1. Conduct comprehensive risk analysis before submission
  2. Perform complete bench testing program including:
    • Material strength testing
    • Activation/deactivation forces
    • Fluid flow and accuracy testing
    • Microbial ingress testing (if applicable)
  3. Execute simulated clinical use testing with:
    • Appropriate sample size (recommended 500 devices)
    • Multiple healthcare professional evaluators
    • Documented training protocol
    • Complete data collection forms
  4. Prepare detailed device documentation including:
    • Complete material composition
    • Physical specifications
    • Mechanical specifications
    • Design features comparison to predicates
  5. Develop comprehensive labeling including:
    • Clear instructions for use
    • Safety warnings
    • Training materials
    • Compatibility information
  6. Ensure compliance with:
    • Design controls
    • Sterilization requirements
    • Biocompatibility testing
    • Applicable standards
  7. Submit 510(k) with complete documentation of all testing and evaluations

Key Considerations

Clinical testing

  • Simulated clinical use testing required with healthcare professionals
  • Study design should include sufficient evaluators and sample size
  • Testing should simulate critical clinical variables
  • Report forms should capture detailed user feedback
  • Failed tests must be reported and explained

Non-clinical testing

  • Bench testing under dry and wet conditions
  • Testing should assess forces, activations, puncture resistance, fluid flow, accuracy
  • Material strength testing (tensile, flexural, elongation)
  • Microbial ingress testing for needleless devices

Human Factors

  • User should easily identify when safety feature is activated
  • Single-handed technique should be possible
  • Safety feature should remain protective through disposal
  • Color coding should follow user conventions
  • Training needs should be evaluated

Labeling

  • Clear intended use statement
  • Detailed directions for use with illustrations
  • Instructions for activation/deactivation
  • Precautions related to hand size/dexterity
  • Warnings about fluid leakage
  • Device description and compatibility information

Biocompatibility

  • Testing according to ISO 10993-1
  • Selection of appropriate tests based on duration and contact
  • Documentation of pass/fail criteria

Safety

  • Device must maintain sterility (SAL of 1x10-6)
  • Safety feature must not be deactivatable once activated
  • Shields must fully enclose sharp and prevent finger access

Other considerations

  • ISO 594: Conical Fittings with a 6% (Luer) Taper for Syringes, Needles, and Certain Other Equipment
  • ANSI/AAMI HE48-1993: Human factors engineering guidelines and preferred practices for the design of medical devices
  • ISO 10993-1: Biological Evaluation of Medical Devices Part 1: Evaluation and Testing

Original guidance

  • Sharps Injury Prevention Features in Medical Devices: Testing and Documentation Requirements
  • HTML / PDF
  • Issue date: 2005-08-08
  • Last changed date: 2020-03-19
  • Status: FINAL
  • Official FDA topics: Medical Devices, Premarket
  • ReguVirta summary file ID: bd4306a2be4ab64a33141d98e0d1248a
This post is licensed under CC BY 4.0 by the author.